Daewoong’s $336 Million Licensing Agreement with CS Pharmaceuticals

Foley Hoag advised Daewoong Pharmaceutical on the deal.South Korea’s Daewoong Pharmaceutical (“Daewoong”) secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based multinational company focused on…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now